 Paul Roberson
Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| TOR Serine-Threonine Kinases | 1 | 2022 | 412 | 0.630 |
Why?
| | Osteoblasts | 9 | 2014 | 126 | 0.430 |
Why?
| | Signal Transduction | 4 | 2022 | 5076 | 0.350 |
Why?
| | Whey Proteins | 2 | 2020 | 6 | 0.320 |
Why?
| | Physical Conditioning, Human | 2 | 2020 | 41 | 0.310 |
Why?
| | Dietary Carbohydrates | 2 | 2020 | 155 | 0.300 |
Why?
| | Bone and Bones | 4 | 2020 | 316 | 0.290 |
Why?
| | Osteogenesis | 7 | 2020 | 186 | 0.280 |
Why?
| | Apoptosis | 9 | 2014 | 2551 | 0.260 |
Why?
| | Ovariectomy | 4 | 2024 | 152 | 0.250 |
Why?
| | Osteocytes | 3 | 2014 | 28 | 0.240 |
Why?
| | Dietary Supplements | 2 | 2020 | 559 | 0.230 |
Why?
| | Wnt Signaling Pathway | 2 | 2018 | 192 | 0.210 |
Why?
| | Hexokinase | 1 | 2022 | 19 | 0.200 |
Why?
| | Rats, Wistar | 1 | 2024 | 455 | 0.200 |
Why?
| | Military Personnel | 2 | 2020 | 544 | 0.200 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 244 | 0.200 |
Why?
| | Estradiol | 3 | 2024 | 518 | 0.190 |
Why?
| | Leucine | 1 | 2022 | 111 | 0.190 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 125 | 0.190 |
Why?
| | Estrogen Receptor alpha | 3 | 2013 | 145 | 0.180 |
Why?
| | HEK293 Cells | 1 | 2022 | 729 | 0.160 |
Why?
| | Atrophy | 2 | 2018 | 184 | 0.160 |
Why?
| | Rats | 4 | 2024 | 5639 | 0.160 |
Why?
| | Androgens | 3 | 2018 | 187 | 0.150 |
Why?
| | Body Composition | 2 | 2024 | 679 | 0.150 |
Why?
| | Osteoclasts | 5 | 2013 | 52 | 0.150 |
Why?
| | Nutritive Value | 1 | 2018 | 37 | 0.150 |
Why?
| | Energy Metabolism | 1 | 2024 | 919 | 0.140 |
Why?
| | Bone Remodeling | 4 | 2014 | 75 | 0.140 |
Why?
| | Glucose | 1 | 2022 | 1019 | 0.140 |
Why?
| | Physical Fitness | 1 | 2018 | 208 | 0.130 |
Why?
| | Parathyroid Hormone | 2 | 2008 | 108 | 0.120 |
Why?
| | Bone Density | 6 | 2020 | 487 | 0.120 |
Why?
| | Estrogens | 4 | 2010 | 367 | 0.120 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2021 | 605 | 0.110 |
Why?
| | Cannabis | 1 | 2021 | 487 | 0.110 |
Why?
| | Oxidative Stress | 3 | 2013 | 1314 | 0.110 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2014 | 15 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2014 | 56 | 0.110 |
Why?
| | Heart Defects, Congenital | 1 | 2021 | 833 | 0.110 |
Why?
| | Animals | 15 | 2024 | 36847 | 0.100 |
Why?
| | Prednisolone | 2 | 2011 | 82 | 0.100 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 190 | 0.100 |
Why?
| | Alendronate | 3 | 2009 | 15 | 0.100 |
Why?
| | Osteoprotegerin | 1 | 2011 | 24 | 0.090 |
Why?
| | Cell Nucleus | 2 | 2013 | 617 | 0.090 |
Why?
| | Aging | 2 | 2014 | 1864 | 0.080 |
Why?
| | Periosteum | 1 | 2008 | 12 | 0.080 |
Why?
| | Receptors, Androgen | 2 | 2018 | 150 | 0.070 |
Why?
| | Bone Density Conservation Agents | 1 | 2009 | 80 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1710 | 0.070 |
Why?
| | Double-Blind Method | 3 | 2020 | 1981 | 0.070 |
Why?
| | Mitosis | 1 | 2008 | 192 | 0.070 |
Why?
| | Femur | 3 | 2014 | 254 | 0.070 |
Why?
| | Glucocorticoids | 1 | 2011 | 593 | 0.070 |
Why?
| | Organ Size | 3 | 2018 | 477 | 0.060 |
Why?
| | Gonadal Steroid Hormones | 1 | 2007 | 140 | 0.060 |
Why?
| | Bone Resorption | 3 | 2020 | 86 | 0.060 |
Why?
| | Mice | 11 | 2014 | 17757 | 0.060 |
Why?
| | Stem Cells | 3 | 2013 | 592 | 0.060 |
Why?
| | Cell Differentiation | 3 | 2010 | 1982 | 0.060 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 41 | 0.050 |
Why?
| | Calcium | 3 | 2020 | 1197 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2003 | 72 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2003 | 67 | 0.050 |
Why?
| | Ovary | 1 | 2024 | 221 | 0.050 |
Why?
| | Body Weight | 2 | 2024 | 985 | 0.050 |
Why?
| | Adiposity | 2 | 2018 | 518 | 0.040 |
Why?
| | Transcription Factors | 2 | 2013 | 1718 | 0.040 |
Why?
| | Female | 13 | 2024 | 72795 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2003 | 434 | 0.040 |
Why?
| | Cells, Cultured | 4 | 2013 | 4191 | 0.040 |
Why?
| | Humans | 10 | 2022 | 136765 | 0.040 |
Why?
| | Calcitonin | 1 | 1999 | 27 | 0.040 |
Why?
| | Diphosphonates | 1 | 1999 | 66 | 0.040 |
Why?
| | Mice, Inbred C57BL | 4 | 2013 | 5749 | 0.040 |
Why?
| | Phosphorylation | 3 | 2010 | 1758 | 0.040 |
Why?
| | Trenbolone Acetate | 1 | 2018 | 9 | 0.040 |
Why?
| | Wnt-5a Protein | 1 | 2018 | 23 | 0.040 |
Why?
| | Cyclins | 1 | 1998 | 91 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2001 | 436 | 0.040 |
Why?
| | Orchiectomy | 1 | 2018 | 71 | 0.040 |
Why?
| | Rats, Inbred F344 | 1 | 2018 | 264 | 0.030 |
Why?
| | Transcriptome | 1 | 2024 | 969 | 0.030 |
Why?
| | Testosterone | 2 | 2018 | 401 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 1998 | 316 | 0.030 |
Why?
| | Physical Endurance | 1 | 2018 | 275 | 0.030 |
Why?
| | Vitamin D | 1 | 2020 | 397 | 0.030 |
Why?
| | Time Factors | 3 | 2018 | 6808 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2018 | 216 | 0.030 |
Why?
| | Steroid 16-alpha-Hydroxylase | 1 | 1996 | 1 | 0.030 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 1996 | 48 | 0.030 |
Why?
| | Nutritional Status | 1 | 2018 | 344 | 0.030 |
Why?
| | Lead | 1 | 1996 | 63 | 0.030 |
Why?
| | Muscle Strength | 1 | 2018 | 317 | 0.030 |
Why?
| | Male | 8 | 2020 | 67311 | 0.030 |
Why?
| | Up-Regulation | 1 | 1998 | 844 | 0.030 |
Why?
| | Liver | 1 | 2024 | 1940 | 0.030 |
Why?
| | Reproduction | 1 | 1996 | 204 | 0.030 |
Why?
| | Interleukin-6 | 1 | 1998 | 778 | 0.030 |
Why?
| | Maternal Exposure | 1 | 1996 | 188 | 0.030 |
Why?
| | Sp7 Transcription Factor | 1 | 2013 | 7 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3539 | 0.030 |
Why?
| | Forkhead Box Protein O3 | 1 | 2013 | 17 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 99 | 0.030 |
Why?
| | Smoking | 1 | 2021 | 1620 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 88 | 0.030 |
Why?
| | Forkhead Box Protein O1 | 1 | 2013 | 33 | 0.030 |
Why?
| | Adipogenesis | 1 | 2013 | 55 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2013 | 117 | 0.030 |
Why?
| | Young Adult | 2 | 2020 | 13127 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3432 | 0.020 |
Why?
| | Bone Marrow | 1 | 2013 | 286 | 0.020 |
Why?
| | Uterus | 1 | 2013 | 215 | 0.020 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 51 | 0.020 |
Why?
| | Spine | 1 | 2013 | 173 | 0.020 |
Why?
| | Cell Line | 2 | 2011 | 2838 | 0.020 |
Why?
| | Pregnancy | 2 | 2021 | 6726 | 0.020 |
Why?
| | Adult | 3 | 2021 | 37631 | 0.020 |
Why?
| | Transcription, Genetic | 2 | 2010 | 1455 | 0.020 |
Why?
| | HeLa Cells | 2 | 2003 | 633 | 0.020 |
Why?
| | Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2010 | 12 | 0.020 |
Why?
| | Shc Signaling Adaptor Proteins | 1 | 2010 | 12 | 0.020 |
Why?
| | Smad1 Protein | 1 | 2010 | 18 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 621 | 0.020 |
Why?
| | Glutathione Reductase | 1 | 2010 | 25 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2010 | 56 | 0.020 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2010 | 66 | 0.020 |
Why?
| | Homeostasis | 1 | 2014 | 619 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2013 | 613 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 171 | 0.020 |
Why?
| | Tartrate-Resistant Acid Phosphatase | 1 | 2009 | 5 | 0.020 |
Why?
| | Acid Phosphatase | 1 | 2009 | 20 | 0.020 |
Why?
| | Thymidine Kinase | 1 | 2008 | 15 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4144 | 0.020 |
Why?
| | Models, Biological | 2 | 2008 | 1773 | 0.020 |
Why?
| | Ganciclovir | 1 | 2008 | 53 | 0.020 |
Why?
| | Membrane Glycoproteins | 2 | 2003 | 500 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2010 | 810 | 0.020 |
Why?
| | Isoenzymes | 1 | 2009 | 304 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 323 | 0.020 |
Why?
| | Collagen Type I | 1 | 2008 | 133 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2163 | 0.020 |
Why?
| | Infant | 1 | 2021 | 9395 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10325 | 0.020 |
Why?
| | DNA Replication | 1 | 2008 | 238 | 0.020 |
Why?
| | Postmenopause | 1 | 2009 | 365 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 846 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2475 | 0.020 |
Why?
| | Biopsy | 1 | 2009 | 1124 | 0.010 |
Why?
| | Phenotype | 1 | 2013 | 3189 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2052 | 0.010 |
Why?
| | bcl-Associated Death Protein | 1 | 2003 | 9 | 0.010 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 9 | 0.010 |
Why?
| | Dactinomycin | 1 | 2003 | 28 | 0.010 |
Why?
| | RANK Ligand | 1 | 2003 | 29 | 0.010 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2003 | 40 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 15504 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 584 | 0.010 |
Why?
| | Culture Media, Conditioned | 1 | 2003 | 110 | 0.010 |
Why?
| | RNA, Messenger | 2 | 2003 | 2831 | 0.010 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 145 | 0.010 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 135 | 0.010 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2003 | 155 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 233 | 0.010 |
Why?
| | Aged | 1 | 2021 | 23794 | 0.010 |
Why?
| | Child | 1 | 2021 | 21819 | 0.010 |
Why?
| | src Homology Domains | 1 | 2001 | 41 | 0.010 |
Why?
| | Estrogen Receptor beta | 1 | 2001 | 40 | 0.010 |
Why?
| | Blotting, Western | 1 | 2003 | 1225 | 0.010 |
Why?
| | Models, Genetic | 1 | 2003 | 599 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2001 | 92 | 0.010 |
Why?
| | Cytoplasm | 1 | 2001 | 272 | 0.010 |
Why?
| | Etidronic Acid | 1 | 1999 | 5 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1664 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 1999 | 124 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2001 | 313 | 0.010 |
Why?
| | Etoposide | 1 | 1999 | 158 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2003 | 769 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1089 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 21382 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2001 | 378 | 0.010 |
Why?
| | Cytokine Receptor gp130 | 1 | 1998 | 12 | 0.010 |
Why?
| | Skull | 1 | 1999 | 139 | 0.010 |
Why?
| | Osteocalcin | 1 | 1998 | 37 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 1998 | 111 | 0.010 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 1998 | 41 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 121 | 0.010 |
Why?
| | Binding Sites | 1 | 2001 | 1301 | 0.010 |
Why?
| | Dexamethasone | 1 | 1999 | 368 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2001 | 705 | 0.010 |
Why?
| | RNA | 1 | 2003 | 921 | 0.010 |
Why?
| | Steroid Hydroxylases | 1 | 1996 | 22 | 0.010 |
Why?
| | Genitalia, Male | 1 | 1996 | 11 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1996 | 97 | 0.010 |
Why?
| | Sexual Maturation | 1 | 1996 | 55 | 0.010 |
Why?
| | Fibroblasts | 1 | 2001 | 993 | 0.010 |
Why?
| | Antigens, CD | 1 | 1998 | 521 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1996 | 155 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 1996 | 185 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1998 | 1350 | 0.010 |
Why?
| | Sex Factors | 1 | 2001 | 2060 | 0.010 |
Why?
| | Base Sequence | 1 | 1998 | 2179 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1999 | 1242 | 0.010 |
Why?
| | Amino Acids | 1 | 1998 | 497 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1998 | 528 | 0.010 |
Why?
| | Vagina | 1 | 1996 | 186 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1249 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1996 | 2486 | 0.010 |
Why?
| | Middle Aged | 1 | 2009 | 33228 | 0.000 |
Why?
|
|
Roberson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|